Who funds inflammatory bowel disease research?

We count 54 funded inflammatory bowel disease projects, active between 2021 and 2034, from 6 funders. The most came from EU · ERC (15 projects), EU · MSCA (12 projects) and Wellcome (10 projects). The median award is $1.7M, across the 49 of 54 projects that list an amount.

Funded projects

54

Funders

6

Median award

$1.7M

Open calls now

0

Top funders of inflammatory bowel disease research

Projects whose title or summary mentions inflammatory bowel disease. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.

Open inflammatory bowel disease funding calls

No open call mentions inflammatory bowel disease in our listings today. We add new calls twice a day; create a free account to get an alert when one opens.

Forecast: announced, not open yet

2 forecast calls on inflammatory bowel disease. Funders publish forecasts before a call opens; you can't apply to these yet, and dates can change.

• ForecastThe NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers
  National Institutes of HealthNot specifiedExpected to open August 1, 2026
• ForecastThe NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating Center
  National Institutes of HealthNot specifiedExpected to open August 1, 2026

Funded inflammatory bowel disease projects

A sample, latest start first, at most three per program.

• Uncovering the biological basis of probiotic non-response in preterm gut health
  Wellcome · £2,627,999 · ends 2034
• Immune checkpoint regulation of the host-microbe interactome
  Wellcome · £3,236,010 · ends 2031
• Investigating Genetic Mechanisms of Tissue Remodelling in the Inflamed Gut
  Wellcome · £1,170,931 · ends 2031
• Patient-specific, combinatorial NAMs for gastrointestinal diseases and drug response prediction
  NIH · NCATS · $3,240,000 · ends 2030
• Identification of bacterial derived proteases that inhibit inflammation and pain signaling in the gut
  NIH · NIDDK · $3,802,100 · ends 2030
• Collaborative Research: Autonomous Smart Capsule for Targeted Drug Delivery in Inflammatory Bowel Disease
  NSF · ENG · $255,000 · ends 2029
• Periodontitis Role in Inflammatory Bowel Disease
  NIH · NIDDK · $3,340,009 · ends 2029
• Finding Needles in Haystacks: First-in-class soloMER drug candidates as precision medicine for autoimmune inflammation diseases.
  UKRI · UKRI FLF · £527,682 · ends 2028
• Inflammatory bowel disease (ibd) which includes crohn's disease and ulcerative colitis involves chronic inflammation of the…
  USDA · $297,579 · ends 2028
• Exploring plasma-cell role in mucosal healing
  EU · MSCA · €236,340 · 2027–2029 · KAROLINSKA INSTITUTET

How we count

Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “inflammatory bowel or crohn or colitis”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.